Abstract
Malignant gastrointestinal neuroectodermal tumor (MGNET) is a sarcoma typically involving the gastrointestinal tract with neuroectodermal differentiation and EWSR1-ATF1/CREB1 fusions. Recently, rare MGNET cases were reported in extragastrointestinal sites. We identified 2 cases of MGNET arising in unprecedented laryngeal and intracranial locations, respectively. Both cases showed spindle and epithelioid tumor cells with amphophilic to clear cytoplasm and occasionally prominent nucleoli, arranged in solid, fascicular, and pseudoalveolar patterns. Case 1 exhibited moderate to marked nuclear atypia and focal intraepithelial component. In contrast, case 2 comprised predominantly low-grade epithelioid cells with extensive pseudopapillary structures. Both tumors showed an S100/SOX10-positive and HMB45/melan-A-negative immunoprofile as well as EWSR1-ATF1 fusion. A chief obstacle in diagnosing case 1 was the histologic and immunophenotypic resemblance to melanoma. The striking pseudopapillary architecture and the intracranial location of case 2 rendered differential diagnoses including meningioma and ependymoma. With the peculiar locations and morphology, these cases posed great diagnostic challenge.
Availability of data and material
Available upon reasonable request.
Code availability
Not applicable.
References
Stockman DL, Miettinen M, Suster S et al (2012) Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract. Am J Surg Pathol 36:857–868. https://doi.org/10.1097/PAS.0b013e31824644ac
Washimi K, Takagi M, Hisaoka M et al (2017) Clear cell sarcoma-like tumor of the gastrointestinal tract: a clinicopathological review. Pathol Int 67:534–536. https://doi.org/10.1111/pin.12573
Kraft S, Antonescu CR, Rosenberg AE et al (2013) Primary clear cell sarcoma of the tongue. Arch Pathol Lab Med 137(11):1680–1683. https://doi.org/10.5858/arpa.2012-0467-CR
Baus A, Culie D, Duong LT et al (2019) Primary clear cell sarcoma of the tongue and surgical reconstruction: about a rare case report. Ann Chir Plast Esthet 64:98–105. https://doi.org/10.1016/j.anplas.2018.09.001
Breton S, Dubois M, Geay JF et al (2019) Clear cell sarcoma or gastrointestinal neuroectodermal tumor (GNET) of the tongue? Case report and review of the literature of an extremely rare tumor localization. Ann Pathol 39(2):167–171. https://doi.org/10.1016/j.annpat.2018.10.004
Sbaraglia M, Zanatta L, Toffolatti L et al (2021) Clear cell sarcoma-like/malignant gastrointestinal neuroectodermal tumor of the tongue: a clinicopathologic and molecular case report. Virchows Arch 478:1203–1207. https://doi.org/10.1007/s00428-020-02933-2
Allanson BM, Weber MA, Jackett LA et al (2018) Oral malignant gastrointestinal neuroectodermal tumour with junctional component mimicking mucosal melanoma. Pathology 50:648–653. https://doi.org/10.1016/j.pathol.2018.07.002
Zheng Q, Chen H, Li Y (2019) Primary gastrointestinal-type clear cell sarcoma–like tumor of the bronchus: a hitherto unreported bronchial tumor. J Thorac Oncol 14:e202–e205. https://doi.org/10.1016/j.jtho.2019.04.030
Yang Y, Chen Y, Chen S, Han A (2021) Malignant gastrointestinal neuroectodermal tumour in soft tissue. Pathology 53:276–278. https://doi.org/10.1016/j.pathol.2020.06.021
Donzel M, Zidane-Marinnes M, Paindavoine S et al (2019) Clear cell sarcoma of the soft palate mimicking unclassified melanoma. Pathology 51:331–334. https://doi.org/10.1016/j.pathol.2018.10.019
Luzar B, Billings SD, de la Fouchardiere A et al (2020) Compound clear cell sarcoma of the skin—a potential diagnostic pitfall: report of a series of 4 new cases and a review of the literature. Am J Surg Pathol 44:21–29. https://doi.org/10.1097/PAS.0000000000001404
Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW (2008) Immunohistochemical characteristics of melanoma. J Cutan Pathol 35:433–444. https://doi.org/10.1111/j.1600-0560.2007.00891.x
Schöffski P, Wozniak A, Stacchiotti S et al (2017) Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE.’ Ann Oncol 28:3000–3008. https://doi.org/10.1093/annonc/mdx527
Subbiah V, Holmes O, Gowen K et al (2016) Activity of c-Met/ALK inhibitor crizotinib and multi-kinase VEGF inhibitor pazopanib in metastatic gastrointestinal neuroectodermal tumor harboring EWSR1-CREB1 fusion. Oncology 91:348–353. https://doi.org/10.1159/000449204
Cornillie J, van Cann T, Wozniak A et al (2016) Biology and management of clear cell sarcoma: state of the art and future perspectives. Expert Rev Anticancer Ther 16:839–845. https://doi.org/10.1080/14737140.2016
Acknowledgements
We thank Mr. Yung-Chuan Chung (NTUH) and Ms. Shih-Chen Yu (KCGMH) for the technical support.
Funding
This work was in part supported by the research fund from the National Taiwan University Hospital (NTUH 108-S4295) to Dr. Jen-Chieh Lee.
Author information
Authors and Affiliations
Contributions
Chien-Tzu Kuo and Jen-Chieh Lee designed the research and wrote the paper. Jen-Chieh Lee, Yu-Chien Kao, and Hsuan-Ying Huang performed molecular analysis. Chien-Tzu Kuo, Jen-Chieh Lee, Yu-Chien Kao, Hsuan-Ying Huang, and Cheng-Hsiang Hsiao interpreted the immunohistochemical stains and contributed to the clinical information, tissue materials, radiologic interpretation, and pathologic diagnosis.
Corresponding author
Ethics declarations
Ethics approval
Waiver(s) available (NTUH-REC No.: 202106035 W).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kuo, CT., Kao, YC., Huang, HY. et al. Malignant gastrointestinal neuroectodermal tumor in head and neck: two challenging cases with diverse morphology and different considerations for differential diagnosis. Virchows Arch 481, 131–136 (2022). https://doi.org/10.1007/s00428-022-03274-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-022-03274-y